Ed retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, softwa Read more
The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.
One of the techniques described in ISO 14971 is Hazard Analysis. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools.
In this
We will explain how to integrate Human Factors studies into the Hazard Analysis and how to integrate Hazard Analysis into the design program.
Course Objectives:
• Understand the new concepts of Hazard Analysis, to avoid confusion
• Why is Hazard Analysis the best technique?
• Learn what terms such as ‘harm’, ‘causative event’, ‘residual risk’ and ‘ALARP’ mean
• Discuss examples of hazards and hazardous situations
• Learn how to deal with residual risk
• Learn how Human Factors studies are integrated into the Hazard Analysis
• Learn how Hazard Analysis is integrated into the design program
Why Should You Attend:
FDA expects that as part of a product development program risk management will be conducted. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard. Hazard Analysis is the most powerful of the risk management tools described in ISO 14971 but it is very confusing. Many new concepts are introduced. We will explain these concepts and provide examples so that the process is clear.
What You Get:
• Training Reference Materials
• Live Q&A with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Engineering personnel
• Software developers, IT
• Management
• Senior Management
• Project Leaders
• Regulatory Affairs
• R&D and Engineering Staff
• All charged with new product development, regulatory submissions, initiating / overseeing product hazard analysis and remediation
• CAPA and P&PC personnel desiring to reduce or redirect investigation and validation costs without sacrificing product safety and/or warranty costs
• Regulatory Personnel
• Product Development Professionals
• Engineers
• QA & QC Professionals
• Medical Device Manufacturer
• Medical Device Designers
• Risk Managers
2-hr Virtual Seminar: FDA Inspections - Understanding the Core Elements
LIVE : Scheduled on
20-May-2024 :01:00 PM EDT
|
21 CFR 58 - Good Laboratory Practice (GLP) and USP 1058 Validations
LIVE : Scheduled on
30-May-2024 :01:00 PM EDT
|
6-Hour Virtual Seminar - Death by CAPA - Does your CAPA Program need a CAPA?
LIVE : Scheduled on
18-June-2024 :11:00 AM EDT
|
6-Hour Virtual Seminar on 21 CFR Part 11 Compliance for Computer Systems Regulated by FDA
LIVE : Scheduled on
19-June-2024 :11:00 AM EDT
|
6-hr Virtual Seminar: Medical Device Regulations and Evolving Requirements: Post Market Surveillance, Complaint Handling, eMDR, Recalls, UDI Regulations & Emerging Signals
LIVE : Scheduled on
25-June-2024 :11:00 AM EDT
|